Silencing of ceramide synthase 2 in hepatocytes modulates plasma ceramide biomarkers predictive of cardiovascular death

Emerging clinical data show that three ceramide molecules, Cer d18:1/16:0, Cer d18:1/24:1, and Cer d18:1/24:0, are biomarkers of a fatal outcome in patients with cardiovascular disease. This finding raises basic questions about their metabolic origin, their contribution to disease pathogenesis, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Steffen, Gallego, Sandra F., Zelnik, Iris Daphne, Kovalchuk, Sergey, Albæk, Nanna, Sprenger, Richard R., Øverup, Charlotte, Pewzner-Jung, Yael, Futerman, Anthony H., Lindholm, Marie W., Jensen, Ole N., Ejsing, Christer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077316/
https://www.ncbi.nlm.nih.gov/pubmed/34400330
http://dx.doi.org/10.1016/j.ymthe.2021.08.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077316/
https://www.ncbi.nlm.nih.gov/pubmed/34400330
http://dx.doi.org/10.1016/j.ymthe.2021.08.021

Ejemplares similares